Metis Global Partners’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
61,604
+3,078
+5% +$121K 0.06% 258
2026
Q1
$2.14M Buy
58,526
+5,709
+11% +$219K 0.05% 285
2025
Q4
$1.91M Buy
52,817
+5,096
+11% +$183K 0.05% 329
2025
Q3
$1.65M Buy
47,721
+16,003
+50% +$526K 0.04% 364
2025
Q2
$971K Buy
31,718
+7,945
+33% +$229K 0.03% 470
2025
Q1
$679K Buy
23,773
+4,507
+23% +$121K 0.02% 535
2024
Q4
$521K Buy
19,266
+3,388
+21% +$101K 0.02% 575
2024
Q3
$490K Buy
15,878
+4,597
+41% +$130K 0.02% 574
2024
Q2
$283K Buy
11,281
+2,441
+28% +$60.5K 0.01% 660
2024
Q1
$215K Buy
+8,840
New +$200K 0.01% 707

Other funds holding CTRE

Metis Global Partners's CTRE Position: Q2 2026 in Review

Metis Global Partners increased its CareTrust REIT (CTRE) stake by 5.3% in Q2 2026, buying an estimated $121K and bringing the position to 61,604 shares worth $2.49M. The position accounts for 0.06% of the portfolio, ranked #258.

Metis Global Partners first reported a position in CTRE in Q1 2024 and has held it in 10 quarters since. 512 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • Metis Global Partners held 61,604 shares of CareTrust REIT worth $2.49M as of Q2 2026.
  • Metis Global Partners bought 3,078 CareTrust REIT shares in Q2 2026, an estimated $121K.
  • CareTrust REIT made up 0.06% of Metis Global Partners's portfolio in Q2 2026, its #258 holding.
  • Metis Global Partners first reported a position in CareTrust REIT in Q1 2024 and has held it in 10 quarters since.
  • 512 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.